Atlas Trials

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

Clinical trial NCT05590455 · RECRUITING

Trial details

NCT number
NCT05590455
Sponsor
ANRS, Emerging Infectious Diseases
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculous MeningitisHIV I Infection
Start date
2023-04-11
Primary completion
2027-06-01
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.